Skip to content
Governance Register

← US public companies

Tricida, Inc.

SEC CIK 1595585 · TCDA · last insider filing 2022-11-25

Directors (from insider filings)

NameCapacity as filedFilings
Orbimed Advisors LLC Director filed 2018 - 2022
Alpern Robert J Director filed 2018 - 2022
Bonita David P Director filed 2018 - 2022
Orbimed Capital GP V LLC Director filed 2018 - 2022
Falberg Kathryn E Director filed 2018 - 2022
Veitinger Klaus R DR Director filed 2018 - 2022
Hirsch David Director filed 2018 - 2022
Coufal Sandra I Director filed 2018 - 2022
Klaerner Gerrit Director · President and CEO filed 2018 - 2022

Officers (from insider filings)

NameTitle as filedFilings
Yoshiyama Annie VP, Finance and CAO filed 2020 - 2022
Parker Geoffrey M. Chief Fin. Officer and Sr. VP filed 2018 - 2022
Otto Dawn Parsell Sr VP, Clinical Development filed 2018 - 2022
Mckague Robert EVP, General Counsel filed 2020 - 2022
Stahl Wilhelm EVP, Chief Tech Officer filed 2018 - 2022
Cantrell Susannah Sr. VP, Chief Comm. Officer filed 2019 - 2020
Cobo Marc SVP, Finance & CAO filed 2020 - 2020
Hejlek Edward J SVP, General Counsel & Secy. filed 2018 - 2020
Pietzke Steffen VP Fin & Chief Acct Officer filed 2018 - 2020
Lockey Claire Chief Dev. Officer and Sr. VP filed 2018 - 2019
VAN Beek Jeroen B Chief Comm Officer and Sr VP filed 2018 - 2018
Buysse Jerry M. Chief Scientific Offr & Sr VP filed 2018 - 2018

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.